Filter
143
Text search:
generics
Featured
Recommendations
14
New Publications
39
Language
Document type
No document type
65
Studies & Reports
43
Guidelines
22
Strategic & Response Plan
6
Manuals
4
Situation Updates
2
Infographics
1
Countries / Regions
Global
10
India
5
Kenya
5
Ghana
4
South Africa
4
Ukraine
4
Philippines
3
Tanzania
3
Namibia
3
Sierra Leone
2
Nigeria
2
Senegal
2
Ethiopia
2
Uganda
2
Haiti
2
Rwanda
2
Indonesia
2
Malawi
2
Lesotho
2
Latin America and the Carribbean
2
Western and Central Europe
2
Burkina Faso
1
Zimbabwe
1
Germany
1
Syria
1
Eswatini/ Swaziland
1
Brazil
1
Botswana
1
Myanmar / Burma
1
East and Southern Africa
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Albania
1
Russia
1
Authors & Publishers
Publication Years
Category
Countries
55
Clinical Guidelines
20
Public Health
10
Pharmacy & Technologies
9
Women & Child Health
2
Toolboxes
Pharmacy
22
HIV
21
AMR
19
NCDs
12
TB
5
COVID-19
5
Mental Health
3
Global Health Education
3
Health Financing Toolbox
3
Conflict
2
Refugee
2
Planetary Health
2
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
WHO recently conducted a survey to assess the availability and cost of a national tracer list of essential medicines in the outpatient sector in Ukraine using a new collection tool – the WHO Essential Medicines and Health Products Price and Availability Monitoring Mobile Application. This tool fac
...
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in global economic development. Although health is widely understood to be both a central goal and an important outcome
...
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate
...
Since the discovery of insulin nearly 100 years ago, advances in diabetes treatments and therapies have transformed the lives of people
with diabetes (PwD), notably reducing the daily burden of its management.
Newer technologies, including those driven by artificial intelligence, have the potentia
...
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been
...
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by the Expert Committee for the 2021 update of the WHO Model List of Essential Medicines (EML) and the Model List of Essential Medicine for Children (EMLc)
...
The purpose of this manual is to define a limited number of indicators that will objectively describe the management and use of antimicrobials in hospitals and to provide tools and step-by-step instructions for designing and carrying out an assessment of antibiotic use and management in hospitals. T
...
The Western Pacific Regional Action Plan for the Prevention and Control of Noncommunicable Diseases (2014–2020) was developed in response to a resolution adopted at the sixty-second session of the WHO Regional Committee for the Western Pacific. The regional plan is fully harmonized with
...
Thefirst report on Latin America and the Carribean presents key indicators on health and health systems in 33 Latin America and the Caribbean countries. . Analysis is based on the latest comparable data across almost 100 indicators including equity, health status, determinants of health, health car
...
Prices people pay for medicines.
